Claritev (CTEV) stock price, chart and financials

Price chart

Revenue (trailing twelve months)

$994.7M

Revenue (quarter)

$257.5M

Revenue growth (year over year)

+6.59%

Gross profit (trailing twelve months)

$725.8M

Gross margin

72.97%

Net income (trailing twelve months)

−$283.1M

Net income (quarter)

−$59.2M

Net income growth (year over year)

+5.45%

Net margin

−28.46%

Return on equity

—

EPS (trailing twelve months)

−$17.00

Book value per share

−$17.39

P/E (trailing twelve months)

—

Price to book

—

Debt to assets

106.04%

Payout ratio

—

Dividend yield

—

Company profile

Claritev Corp is a healthcare technology, data, and insights company focused on improving transparency, affordability, and quality. The company provides tech-enabled solutions and services to interpret clients' needs and customize solutions that combine its payment integrity, network-based, and analytics-based services. The company's focus is on being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the U.S. healthcare industry.

• Is Claritev (CTEV) profitable?

  No. Claritev reported a net loss of $283.1M over the trailing twelve months.

• How much revenue does Claritev (CTEV) make?

  Claritev generated $994.7M in revenue over the trailing twelve months, up 6.59% year over year.

• How do I buy stock in Claritev (CTEV)?

  CTEV trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.